4.5 Article

Identification of α2-Macroglobulin as a Master Inhibitor of Cartilage-Degrading Factors That Attenuates the Progression of Posttraumatic Osteoarthritis

Journal

ARTHRITIS & RHEUMATOLOGY
Volume 66, Issue 7, Pages 1843-1853

Publisher

WILEY
DOI: 10.1002/art.38576

Keywords

-

Categories

Funding

  1. NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [R01-AR-059142]
  2. NIH (National Institute of General Medical Sciences) [R01-CA-166089]
  3. NIH (National Center for Research Resources) [P20-RR-024484]
  4. National Natural Science Foundation of China [81071495, 81171676, 81201435]
  5. Natural Science Foundation of Shanxi [2011011042]
  6. Arthritis National Research Foundation

Ask authors/readers for more resources

Objective. To determine if supplemental intra-articular alpha(2)-macroglobulin (alpha M-2) has a chondroprotective effect in a rat model of osteoarthritis (OA). Methods. Using Western blotting, mass spectrometry, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry, alpha M-2 was identified as a potential therapeutic agent through a comparison of alpha M-2 concentrations in serum, synovial fluid (SF), and cartilage from normal subjects and patients with OA. In cultured chondrocytes, the effects of alpha M-2 on interleukin-1 (IL-1)-induced cartilage catabolic enzymes were evaluated by Luminex assay and ELISA. In vivo effects on cartilage degeneration and matrix metalloproteinase 13 (MMP-13) concentration were evaluated in male rats (n = 120) randomized to 1 of 4 treatments: 1) anterior cruciate ligament transection (ACLT) and saline injections, 2) ACLT and 1 IU/kg injections of alpha M-2, 3) ACLT and 2 IU/kg injections of alpha M-2, or 4) sham operation and saline injections. Rats were administered intraarticular injections for 6 weeks. The concentration of MMP-13 in SF lavage fluid was measured using ELISA. OA-related gene expression was quantified by real-time quantitative polymerase chain reaction. The extent of OA progression was graded by histologic examination. Results. In both normal subjects and OA patients, alpha M-2 levels were lower in SF as compared to serum, and in OA patients, MMP-13 levels were higher in SF than in serum. In vitro, alpha M-2 inhibited the induction of MMP-13 by IL-1 in a dose-dependent manner in human chondrocytes. In the rat model of ACLT OA, supplemental intraarticular injection of alpha M-2 reduced the concentration of MMP-13 in SF, had a favorable effect on OA-related gene expression, and attenuated OA progression. Conclusion. The plasma protease inhibitor alpha M-2 is not present in sufficient concentrations to inactivate the high concentrations of catabolic factors found in OA SF. Our findings suggest that supplemental intraarticular alpha M-2 provides chondral protection in post-traumatic OA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available